Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study

Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study

In the SCOPE study, we monitored SARS-CoV-2 antibodies in a national sample of residents and staff from Belgian nursing homes. Here, we report the seroprevalence among infected and infection-naive residents and staff after the primary COVID-19 vaccination campaign. Among 1554 vaccinated nursing home...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Eline Meyers, Ellen Deschepper, Els Duysburgh, Liselore De Rop, Tine De Burghgraeve, Pauline Van Ngoc, Marina Digregorio, Simon Delogne, Anja Coen, Nele De Clercq, Laëtitia Buret, Samuel Coenen, An De Sutter, Beatrice Scholtes, Jan Y Verbakel, Piet Cools, Stefan Heytens
Formatua: Artikulua
Hizkuntza:English
Argitaratua: MDPI AG 2022-10-01
Saila:Viruses
Gaiak:
seroprevalence
SARS-CoV-2
IgG
IgM
nursing home residents
elderly
Sarrera elektronikoa:https://www.mdpi.com/1999-4915/14/11/2361

Internet

https://www.mdpi.com/1999-4915/14/11/2361

Antzeko izenburuak